{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:07:45Z","timestamp":1785859665736,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["PY2023010"],"award-info":[{"award-number":["PY2023010"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["YKK22239"],"award-info":[{"award-number":["YKK22239"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jiph.2025.103025","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:03:55Z","timestamp":1761678235000},"page":"103025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the relative effectiveness of various antibiotic regimens used to treat hospital-acquired pneumonia induced by drug-resistant Acinetobacter baumannii"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3147-5688","authenticated-orcid":false,"given":"Liang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Pu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jiph.2025.103025_bib1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3390\/microorganisms13091983","article-title":"Carbapenem-resistant acinetobacter baumannii: virulence factors, molecular epidemiology, and latest updates in treatment options","volume":"13","author":"Karampatakis","year":"2025","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.jiph.2025.103025_bib2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/microorganisms13081819","article-title":"Current methods for reliable identification of species in the acinetobacter calcoaceticus-acinetobacter baumannii complex","volume":"13","author":"Marinova-Bulgaranova","year":"2025","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.jiph.2025.103025_bib3","first-page":"488","article-title":"Management of MDR\/XDR severe infections in the critically ill","volume":"31","author":"Mezzadri","year":"2025","journal-title":"Curr Opin Crit Care"},{"issue":"3","key":"10.1016\/j.jiph.2025.103025_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00279-24","article-title":"Drug-resistant Acinetobacter baumannii: mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen","volume":"38","author":"Dubey","year":"2025","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.jiph.2025.103025_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/phar.2607","article-title":"Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: how viable are the current options?","volume":"41","author":"O'Donnell","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jiph.2025.103025_bib6","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1080\/22221751.2022.2093134","article-title":"Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (ICUs) in China","volume":"11","author":"Liu","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"10.1016\/j.jiph.2025.103025_bib7","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious diseases society of america guidance on the treatment of AmpC beta-lactamase-producing enterobacterales, carbapenem-resistant acinetobacter baumannii, and stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.103025_bib8","unstructured":"Clinical and Laboratory Standards Institute. M100: performance standards for antimicrobial susceptibility testing. 31st ed. Wayne, PA: Clinical and Laboratory Institutes 2021."},{"issue":"3","key":"10.1016\/j.jiph.2025.103025_bib9","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jiph.2025.103025_bib10","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jiph.2025.103025_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.51445","article-title":"Defining posttraumatic sepsis for population-level research","volume":"6","author":"Stern","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jiph.2025.103025_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00698-21","article-title":"Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant enterobacterales","volume":"65","author":"Chen","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jiph.2025.103025_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.jiph.2025.103025_bib14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10096-014-2070-6","article-title":"Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections","volume":"33","author":"Batirel","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2025.103025_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijantimicag.2016.07.007","article-title":"Clinical epidemiology, treatment, and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients","volume":"48","author":"Tsioutis","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jiph.2025.103025_bib16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/microorganisms11061603","article-title":"Association of virulence, biofilm, and antimicrobial resistance genes with specific clonal complex types of listeria monocytogenes","volume":"11","author":"Myintzaw","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.jiph.2025.103025_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1602636","article-title":"Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid in immunocompromised patients with pneumonia","volume":"15","author":"Xin","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103025_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13054-025-05573-7","article-title":"The effects of vasopressor choice on renal outcomes in septic shock: a systematic review of randomised trials as a guide for future research","volume":"29","author":"McDonald","year":"2025","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jiph.2025.103025_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.202009-3575OC","article-title":"Survival in immunocompromised patients ultimately requiring invasive mechanical ventilation: a pooled individual patient data analysis","volume":"204","author":"Dumas","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jiph.2025.103025_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/wound.2020.1319","article-title":"Advanced wound diagnostics: toward transforming wound care into precision medicine","volume":"11","author":"Weigelt","year":"2022","journal-title":"Adv Wound Care (N Rochelle)"},{"key":"10.1016\/j.jiph.2025.103025_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/IDR.S357746","article-title":"Polymyxin B-based regimens for patients infected with carbapenem-resistant gram-negative bacteria: clinical and microbiological efficacy, mortality, and safety","volume":"15","author":"Qu","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"6","key":"10.1016\/j.jiph.2025.103025_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00433-22","article-title":"Acinetobacter metabolism in infection and antimicrobial resistance","volume":"91","author":"Ren","year":"2023","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiph.2025.103025_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13756-019-0502-x","article-title":"Comparison of tigecycline or cefoperazone\/sulbactam therapy for bloodstream infection due to carbapenem-resistant acinetobacter baumannii","volume":"8","author":"Niu","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"10.1016\/j.jiph.2025.103025_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diagmicrobio.2010.05.012","article-title":"Comparison of tigecycline with imipenem\/cilastatin for the treatment of hospital-acquired pneumonia","volume":"68","author":"Freire","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2025.103025_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/mdr.2022.0248","article-title":"Tigecycline-containing regimens and multi-drug-resistant acinetobacter baumannii: a systematic review and meta-analysis","volume":"29","author":"Sodeifian","year":"2023","journal-title":"Micro Drug Resist"},{"issue":"3","key":"10.1016\/j.jiph.2025.103025_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3947\/ic.2024.0038","article-title":"Guidelines for antibacterial treatment of carbapenem-resistant enterobacterales infections","volume":"56","author":"Park","year":"2024","journal-title":"Infect Chemother"},{"issue":"7","key":"10.1016\/j.jiph.2025.103025_bib27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","article-title":"Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review","volume":"41","author":"Yaghoubi","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2025.103025_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.772372","article-title":"Polymyxin B\/Tigecycline Combination vs. Polymyxin B or tigecycline alone for the treatment of hospital-acquired pneumonia caused by carbapenem-resistant enterobacteriaceae or carbapenem-resistant acinetobacter baumannii","volume":"9","author":"Chang","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.jiph.2025.103025_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijantimicag.2014.10.002","article-title":"In vitro synergies of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis","volume":"45","author":"Ni","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiph.2025.103025_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40121-022-00597-w","article-title":"Carbapenem-resistant acinetobacter baumannii: colonization, infection and current treatment options","volume":"11","author":"Bartal","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"8","key":"10.1016\/j.jiph.2025.103025_bib31","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cmi.2017.10.033","article-title":"Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii","volume":"24","author":"Liang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2025.103025_bib32","series-title":"Trial for the treatment of extensively drug-resistant gram-negative bacilli","author":"Kaye","year":"2021"},{"issue":"4","key":"10.1016\/j.jiph.2025.103025_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.103025_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.770518","article-title":"Limitations of antibiotic MIC-Based PK-PD metrics: looking back to move forward","volume":"12","author":"Landersdorfer","year":"2021","journal-title":"Front Pharm"},{"issue":"3","key":"10.1016\/j.jiph.2025.103025_bib35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s12325-020-01235-y","article-title":"Effectiveness and safety of high-dose tigecycline for the treatment of severe infections: a systematic review and meta-analysis","volume":"37","author":"Zha","year":"2020","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.jiph.2025.103025_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/antibiotics13030287","article-title":"High-loading-dose colistin with nebulized administration for carbapenem-resistant acinetobacter baumannii pneumonia in critically Ill patients: a retrospective cohort study","volume":"13","author":"Katip","year":"2024","journal-title":"Antibioics"},{"issue":"6","key":"10.1016\/j.jiph.2025.103025_bib37","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/pharmaceutics14061266","article-title":"Effectiveness and nephrotoxicity of loading dose colistin-meropenem versus loading dose colistin-imipenem in the treatment of carbapenem-resistant acinetobacter baumannii infection","volume":"14","author":"Katip","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.jiph.2025.103025_bib38","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jiph.2023.05.024","article-title":"Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: a propensity score matching study","volume":"16","author":"Katip","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2025.103025_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1231740","article-title":"Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis","volume":"13","author":"Sophonsri","year":"2023","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:13:50Z","timestamp":1785856430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125003740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1876034125003740"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103025","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the relative effectiveness of various antibiotic regimens used to treat hospital-acquired pneumonia induced by drug-resistant Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103025"}}